Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 5
2008 3
2009 12
2010 7
2011 12
2012 10
2013 12
2014 8
2015 5
2016 9
2017 14
2018 9
2019 9
2020 15
2021 10
2022 8
2023 9
2024 8
2025 10
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study.
Breccia M, Giai V, Rosso T, Pregno P, Castagnetti F, Bonifacio M, Capodanno I, Tiribelli M, Stagno F, Caocci G, Gozzini A, Patriarca A, Sorà F, Loglisci G, Rossi AR, Coppi MR, Miggiano MC, Di Raimondo F, Galimberti S, Rosti G, Melillo L, Pane F, Saglio G, Ciccone G, Specchia G. Breccia M, et al. Among authors: castagnetti f. Ann Hematol. 2026 Apr 18;105(5):252. doi: 10.1007/s00277-026-07012-1. Ann Hematol. 2026. PMID: 41999487 Free PMC article.
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.
Lauseker M, Sacha T, Klamova H, Yakoleva J, Lomaia E, Milojkovic D, Fabisch C, Nicolini FE, Olsson-Stromberg U, Zackova D, Lewandowski K, Ernst P, Castagnetti F, Hirschbühl K, Zupan I, Voskanyan A, Gołos A, Frietsch JJ, Gil J, Faber E, Krause SW, Parry A, Saussele S, Heibl S, Franke GN, Casado LF, Paczkowska E, Hebart H, Eder M, Anhut P, Trautmann-Grill K, Szczepanek E, Südhoff T, Patkowska E, Kiani A, Ernst T, Apperley J, Mayer J, Hochhaus A, Pfirrmann M, Brioli A. Lauseker M, et al. Among authors: castagnetti f. Leukemia. 2026 Apr;40(4):751-758. doi: 10.1038/s41375-026-02875-9. Epub 2026 Feb 19. Leukemia. 2026. PMID: 41714405 Free PMC article.
Second attempt to discontinue TKI after molecular relapse in patients with chronic myeloid leukemia: A real-life Italian multicenter study.
Iurlo A, Cattaneo D, Fava C, Castagnetti F, Bonifacio M, D'Adda M, Miggiano MC, Capodanno I, Elena C, Levato L, Scortechini AR, Lunghi F, Caramella M, Orofino N, Maffioli M, Bellani V, Bonuomo V, Grano S, Cotilli G, Scalzulli E, Dalmazzo M, Crescenzi SL, Luciano L, Martino B, Intermesoli T, Rapezzi D, Binotto G, Tiribelli M, Consonni D, Pane F, Saglio G, Gambacorti-Passerini C, Breccia M, Rosti G. Iurlo A, et al. Among authors: castagnetti f. Cancer. 2026 Feb 1;132(3):e70261. doi: 10.1002/cncr.70261. Cancer. 2026. PMID: 41562413
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study.
Breccia M, Giai V, Rosso T, Pregno P, Castagnetti F, Bonifacio M, Capodanno I, Tiribelli M, Stagno F, Mulas O, Gozzini A, Patriarca A, Sorà F, Loglisci G, Rossi AR, Coppi MR, Miggiano MC, Di Raimondo F, Rosti G, Pane F, Saglio G, Ciccone G, Specchia G. Breccia M, et al. Among authors: castagnetti f. Br J Haematol. 2026 Mar;208(3):974-980. doi: 10.1111/bjh.70332. Epub 2026 Jan 11. Br J Haematol. 2026. PMID: 41521026
GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologists.
Breccia M, Piciocchi A, Abruzzese E, Cilloni D, Castagnetti F, Messina M, Soddu S, Scappini B, Markovic U, Annunziata M, Malato A, Binotto G, Mulas O, Bonifacio M, Fazi P, Pane F. Breccia M, et al. Among authors: castagnetti f. Front Oncol. 2025 Nov 18;15:1697569. doi: 10.3389/fonc.2025.1697569. eCollection 2025. Front Oncol. 2025. PMID: 41341405 Free PMC article.
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint.
Castagnetti F, Breccia M, Abruzzese E, Bassan R, Binotto G, Bonifacio M, Caocci G, Capodanno I, Cavazzini F, Cimino G, Fazi P, Gozzini A, Iurlo A, Janssen JJWM, Lunghi M, Marasca R, Martino B, Messina M, Muriano F, Paoloni F, Piciocchi A, Rosti G, Russo Rossi A, Saglio G, Sica S, Soverini S, Tafuri A, Vallisa D, Westerweel PE, Pane F. Castagnetti F, et al. Leukemia. 2026 Jan;40(1):47-54. doi: 10.1038/s41375-025-02796-z. Epub 2025 Nov 18. Leukemia. 2026. PMID: 41254114 Free PMC article. Clinical Trial.
The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial.
Efficace F, Cannella L, Capodanno I, Sancetta R, Porcu V, Lunghi M, Biagi A, Castagnetti F, Caocci G, Baldi T, Marasca R, Bonifacio M, Gozzini A, Martino B, Sora F, Westerweel PE, Fazi P, Vignetti M, Pane F, Breccia M. Efficace F, et al. Among authors: castagnetti f. Front Oncol. 2025 Aug 27;15:1645217. doi: 10.3389/fonc.2025.1645217. eCollection 2025. Front Oncol. 2025. PMID: 40936723 Free PMC article.
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.
Apperley JF, Milojkovic D, Cross NCP, Hjorth-Hansen H, Hochhaus A, Kantarjian H, Lipton JH, Malhotra H, Niederwieser D, Radich J, Rousselot P, Saussele S, Schiffer CA, Silver R, Soverini S, Stenke L, Turkina A, Casado LF, Castagnetti F, Cervantes F, Clark RE, Cortes J, Deininger M, Hughes TP, Janssen J, Jiang Q, Kim DW, Larson RA, Mahon FX, Mauro M, Mayer J, Nicolini FE, Pane F, Rea D, Richter J, Rosti G, Saglio G, Hehlmann R. Apperley JF, et al. Among authors: castagnetti f. Leukemia. 2025 Aug;39(8):1797-1813. doi: 10.1038/s41375-025-02664-w. Epub 2025 Jul 11. Leukemia. 2025. PMID: 40646132 Free PMC article.
Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus.
Giai V, Rosso T, Castagnetti F, Pregno P, Bonifacio M, Capodanno I, Tiribelli M, Stagno F, Caocci G, Gozzini A, Luciano L, Galimberti S, Bocchia M, Patriarca A, Lanzarone G, Martino B, Guella A, Scortechini AR, Fava C, Fozza C, Sica S, Di Renzo N, Musto P, Pastore D, Maggi A, Pizzuti M, Melillo LMA, Carella AM, Tarantini G, Mele A, Calistri E, Coppi MR, Saccona F, Scalzulli E, Battaglio B, Iezza M, Bitetti C, Freilone R, Rosti G, Albano F, Pane F, Specchia G, Ciccone G, Saglio G, Breccia M. Giai V, et al. Among authors: castagnetti f. Cancer. 2025 Jul 1;131(13):e35963. doi: 10.1002/cncr.35963. Cancer. 2025. PMID: 40581844 Free PMC article.
Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database.
Stagno F, Cucci R, Marsili G, Castagnetti F, Galimberti S, Izzo B, Sorà F, Soverini S, Messina M, Piciocchi A, Bonifacio M, Cilloni D, Iurlo A, Martinelli G, Rosti G, Fazi P, Vignetti M, Breccia M, Allegra A, Pane F. Stagno F, et al. Among authors: castagnetti f. Am J Hematol. 2025 Aug;100(8):1467-1470. doi: 10.1002/ajh.27733. Epub 2025 Jun 5. Am J Hematol. 2025. PMID: 40470709 Free PMC article. No abstract available.
159 results